PPARG and Hypertension: This idea is supported by work with a dominant negative P467L mutation in the ligand-binding domain of PPARγ.  In humans the P467L mutation is associated with severe insulin resistance and hypertension [44] and homozygous mice with the equivalent P465L mutation die in utero [44].